Select Medical (NYSE:SEM) Upgraded to Buy at StockNews.com

StockNews.com upgraded shares of Select Medical (NYSE:SEM) from a hold rating to a buy rating in a research report sent to investors on Monday morning.

Other analysts also recently issued research reports about the stock. Benchmark downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Royal Bank of Canada lifted their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, UBS Group cut their price objective on shares of Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $39.50.

Select Medical Trading Up 3.5 %

NYSE:SEM opened at $20.36 on Monday. Select Medical has a 52 week low of $18.02 and a 52 week high of $40.98. The firm’s fifty day moving average is $21.64 and its 200-day moving average is $30.47. The firm has a market cap of $2.64 billion, a P/E ratio of 9.51, a P/E/G ratio of 0.65 and a beta of 1.45. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The firm had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same period last year, the business posted $0.46 EPS. The business’s revenue was up 5.7% compared to the same quarter last year. Equities analysts expect that Select Medical will post 1.97 earnings per share for the current year.

Select Medical Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were issued a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 2.46%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s payout ratio is currently 23.36%.

Insider Activity at Select Medical

In other news, VP Robert G. Breighner, Jr. sold 4,989 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the transaction, the vice president now owns 30,356 shares of the company’s stock, valued at approximately $605,602.20. The trade was a 14.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Marilyn B. Tavenner sold 32,000 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now directly owns 22,000 shares in the company, valued at $463,980. The trade was a 59.26 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Geode Capital Management LLC grew its position in shares of Select Medical by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 2,442,321 shares of the health services provider’s stock worth $85,180,000 after buying an additional 46,880 shares during the last quarter. Principal Financial Group Inc. boosted its holdings in Select Medical by 6.7% in the third quarter. Principal Financial Group Inc. now owns 2,357,823 shares of the health services provider’s stock valued at $82,208,000 after acquiring an additional 147,032 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its position in shares of Select Medical by 1.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,646,320 shares of the health services provider’s stock worth $57,407,000 after purchasing an additional 24,439 shares during the period. Finally, Victory Capital Management Inc. increased its position in shares of Select Medical by 0.6% during the third quarter. Victory Capital Management Inc. now owns 1,181,078 shares of the health services provider’s stock valued at $41,184,000 after buying an additional 7,372 shares during the period. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.